A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. Exagen Inc’s current trading price is 9.14% away from its 52-week high, while its distance from the 52-week low is 340.67%. The stock’s price range for this time frame has been between $1.30 and $5.25. The trading volume of the company’s shares in the Healthcare reached around 0.7 million for the day, which was evidently higher than the average daily volume of 54320.0 over the last three months.
Exagen Inc’s stock has seen a smooth market performance. The company’s stock achieved a 1-year high of $5.25 on 12/12/24, and the lowest price during that time was $1.30, recorded on 04/16/24.
How Financial Performance Impacts Market Capitalization
Exagen Inc (XGN) has experienced a quarterly rise of 93.58% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 101.06M and boasts a workforce of 179 employees.
The Role of Moving Averages and Trading Volume in Technical Analysis
Based on Barchart.com data, the company’s moving average over the 100-day period was 3.05, with a change in price of +3.74. Similarly, Exagen Inc recorded 69,691 in trading volume during the last 100 days, posting a change of +187.94%.
How XGN’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for XGN stands at 1.83. Similarly, the long-term debt-to-equity ratio is also 1.69.
XGN Stock Stochastic Average
Exagen Inc’s raw stochastic average for the past 50 days is currently at 87.47%. This represents a surge from the raw stochastic average of the last 20 days, which was recorded at 86.25%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 83.35% and 80.03%, respectively.
XGN Stock Price Performance Analysis
A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. Year to date metric has recorded a gain of 187.94%.However, over the last six months, we can see a weaker performance of 189.39%. Over the last 30 days, the price of XGN has fallen by 105.38%. And in the last five days, it has surged by 29.64%.
